Quantcast

Latest Sufentanil Stories

2011-08-11 06:30:00

REDWOOD CITY, Calif., Aug. 11, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, reported financial results today for the second quarter and six months ended June 30, 2011. Net loss for the second quarter of 2011 was $4.8 million, or $0.25 per share, compared with a net loss of $3.5 million, or $5.41 per...

2011-08-10 06:30:00

REDWOOD CITY, Calif., Aug. 10, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and Chief Executive Officer, will present at the Canaccord Genuity Growth Conference in Boston, MA at the InterContinental Hotel. The presentation is scheduled for Thursday, August 11, 2011 at...

2011-08-04 15:05:00

CUPERTINO, Calif., Aug. 4, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended June 30, 2011. Total revenues increased to $7.8 million for the three months ended June 30, 2011 from $7.3 million for the three months ended June 30, 2010. Net loss for the three months ended June 30, 2011 was $5.2 million, compared to a net loss of $6.3 million for the same period in 2010. (Logo:...

2011-07-28 15:15:00

CUPERTINO, Calif., July 28, 2011 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2011 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, August 4, 2011 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2011-06-30 12:30:00

REDWOOD CITY, Calif., June 30, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) (AcelRx) today announced that it has obtained a $20 million secured loan agreement with Hercules Technology Growth Capital (Hercules). Upon the execution of this agreement with Hercules, AcelRx received $10 million in the first tranche of the loan. The second tranche of up to $10 million can be drawn, at AcelRx's option, any time prior to December 16, 2011. In addition, AcelRx announced that...

2011-06-03 07:30:00

CUPERTINO, Calif., June 3, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Jim Brown, President and CEO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June 7 at 4:30 p.m. Eastern time. The conference is being held at the Grand Hyatt in New York. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at www.durect.com and clicking "Investor...

2011-06-02 15:15:00

CUPERTINO, Calif., June 2, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Joseph Stauffer, Chief Medical Officer and Executive Vice President, Corporate Strategy has resigned effective June 21, 2011 to pursue other opportunities. Dr. Stauffer and DURECT have entered into a consulting agreement through December 31, 2011. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) "We appreciate all of Joe's efforts over the last two years, most notably in...

2011-05-31 06:30:00

REDWOOD CITY, Calif., May 31, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)(AcelRx), today announced that the US Army Medical Research and Material Command (USAMRMC) has awarded AcelRx a $5.6 million grant to support the development of a new product candidate, ARX-04, a proprietary non-invasive, fast-onset sublingual product for the treatment of moderate-to-severe acute pain. Commenting on the award, Richard King, AcelRx President and Chief Executive Officer stated,...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.